Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q2 FY22 results · Jul–Sep 2021
Bajaj Healthcare reported revenue from operations of ₹150.91 crore (down 27.0% from Q2 FY21) and net profit of ₹17.25 crore (down 14.2% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 150.91 | 206.63 | −27.0% | 185.69 | −18.7% |
| Other income | 0.12 | 2.09 | −94.3% | 0.68 | −82.6% |
| Total income | 151.03 | 208.73 | −27.6% | 186.37 | −19.0% |
| Profit before tax | 22.18 | 28.26 | −21.5% | 27.25 | −18.6% |
| Net profit for the period | 17.25 | 20.12 | −14.2% | 19.22 | −10.2% |
| EPS, basic (₹) | 6.25 | 14.58 | not comparable | 13.93 | not comparable |
| Net margin (%) | 11.4 | 9.7 | 10.3 |
Standalone
- Filed with BSE
- 03 Nov 2021, 14:45 IST
- Board meeting
- 02 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE